Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trialJ. Guigay, Franck Darloy, Cédrik Lafond et al.|The Lancet Oncology|2021Cited by 231
Persistent elevation of plasma vitamin B12 is strongly associated with solid cancerValentin Lacombe, G. Urbanski, Floris Chabrun et al.|Scientific Reports|2021Cited by 54